Don't miss a thing by getting the day's biggest stories sent direct to your inbox All those aged under 40 are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine in a precautionary move.
The Joint Committee on Vaccination and Immunisation (JCVI) and the Medicines and Healthcare products Regulatory Agency (MHRA) are expected to say there are no new safety concerns after previous data showed the AstraZeneca jab was linked to very rare blood clots.
A press conference will be held on Friday morning between the JCVI and the MHRA. Previously, the MHRA said the balance of risk for the AstraZeneca vaccine against Covid is very favourable for older people but “more finely balanced” for younger groups, who do not tend to suffer
Read more on manchestereveningnews.co.uk